healthcareguru: June 2020

Thursday, June 25, 2020

Insulinoma Treatment Market Emerging Technologies, Competition & Strategies of Key Players, Regional Analysis and Forecast By 2023

Insulinoma Market Information: By Types (Benign, Metastasize) By Diagnosis (Blood Test, Endoscopic Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Others), Treatment (Surgery, Drugs, Radiofrequency Ablation, Chemotherapy, Others) By End User – Global Forecast Till 2023

Market Outlook

Insulinomas are tumors formed on the pancreas which raise insulin levels and cause blood sugar levels to drop. Some of the genetic diseases which can cause these tumors include multiple endocrine neoplasia type 1, Von-Hippel Landau syndrome, and others. The global Insulinoma Treatment Market report compiled by Market Research Future (MRFR) consists of pertinent drivers, restraints, and opportunities for growth.

The global Insulinoma Treatment Market size can touch USD 3.3 billion by 2023 while exhibiting a year-on-year growth rate of 3.3% during the forecast period (2017-2023). The market is driven by the number of diabetics and the vulnerability to being afflicted to the disease. According to the research conducted by MRFR, close to 10% of patients with insulinomas are diagnosed with malignant and affect between 1-5 people out of a million. The surge in surgeries such as embolization as well as technological advances in laparoscopic surgery can drive the market demand exponentially.

Product development as well as upgrades in technology hold the key to eradicating the disease. In addition, minimally invasive surgeries and development of miniature equipment and tools can drive the market demand. The rising use of dietary therapy combined with enteral feeds can keep malignant tumors at bay. Glucagon is one of the most preferred treatment for controlling sugar levels. Keeping this in mind, Lilly Diabetes, an arm of Eli Lilly and Company, has launched an Android version of the application which provide caregivers with information on injecting patients with the right dosage and alerts customers of the expiration date of kits.

Segmentation:

MRFR segments the global Insulinoma Treatment Market by type, diagnosis, treatment, and end-user.

Based on the type, the Insulinoma Treatment Market can be segmented into benign and metastasize.

Based on diagnosis, the Insulinoma Treatment Market includes magnetic resonance imaging (MRI), computed tomography (CT), endoscopic ultrasound, blood test, and others.

Based on treatment, the Insulinoma Treatment Market comprises chemotherapy, surgery, radiofrequency ablation, and drugs.

Based on end-user, the market targets academic & research, hospitals & clinics, and others.

Request For Free Sample Copy :

https://www.marketresearchfuture.com/sample_request/4437

Regional Analysis:

The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are the four major regions in which the region-specific analysis of the global Insulinoma Treatment Market has been segmented.

The Americas accounted for a majority of the global market and will be dominant during the forecast period. Large allocation of healthcare expenditure for the welfare of the public and extensive reliance on medications are factors driving the regional Insulinoma Treatment Market. Uptick in the development of new products and number of surgeries are other major developments which can bode well.

Europe is the second biggest region for the global Insulinoma Treatment Market due to the large number of bariatric surgeries and diabetics. Large healthcare sector and high expendable income levels of patients can be lucrative for the market in the region. France, Germany, and the U.K. are countries expected to contribute the maximum to the global Insulinoma Treatment Market.

The APAC region is projected to exhibit a robust CAGR during the forecast period due to countries of China and India. Unmet needs and measures undertaken by various pharmaceutical companies to keep hypoglycemia levels under check can bode well for the region.

Competitive Landscape:

Medtronic, Cook Medical Inc., Pfizer Plc., Boston Scientific Corporation, Abcam plc, Olympus, Entax Medical, Ciron Drugs & Pharmaceutical Ltd., and others are prominent companies profiled in the global Insulinoma Treatment Market report.

Industry News

Researchers at the Queen Mary University of London have discerned the presence of a new gene, MAFA, which holds the key to dispensing insulin and be instrumental in the treatment of all types of diabetes. This study was conducted using the families containing diabetes and insulinomas due to the defective gene.

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.

Inguinal Hernia Market Size – Rising New Technologies Research Forecast to 2023

Inguinal hernia is a condition in which a part of small intestine bulges through its walls. It is one of the types of hernia, which is the most common in both the developing and developed countries across the globe.The global Inguinal Hernia Market is expected to show a high growth over the forecast period owing to rising number of patients with inguinal hernia and increasing number of surgical procedures performed for hernia repair. Furthermore, growing demand for hernia repair devices boost the market growth. However, high cost hernia repair devices restrains the growth of the market in nations in Africans region and other developing countries.

Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Inguinal Hernia Repair Market Size research report–Global forecast till 2023.”

Major Players in Inguinal Hernia Repair Market Size
Some of the key players in the global market are Ethicon, Inc. (U.S.), Medtronic (U.S.), C.R. Bard, Inc. (U.S.), Atrium (U.S.), W.L. Gore & Associates Inc. (U.S.), Acelity (U.S.), and B Braun Melsungen AG (Germany).

Regional Analysis:

America is the largest market for inguinal hernia owing to rising prevalence in the U.S. and increasing surgical procedures cases such as groin hernia repair.

Europe is the second largest market owing to increasing prevalence of inguinal hernia and extensive demand for hernia repair devices. The U.K is expected to be the largest market in Europe over the review period. According to the New England Journal of Medicine, in 2014 more than 90,000 surgical intervention for inguinal hernia were performed in Europe.

In Asia Pacific, rising demand for laparoscopic procedures for inguinal hernia. India is expected to be the largest market in Asia Pacific followed by China and Japan.
The Middle East & Africa also shows a steady rise in the market owing to extensive use of hernia mesh devices for surgeries in the Middle East. In the Middle East, Iran is expected to be the largest market followed by Saudi Arabia. In Africa, high cost of hernia repair restrained the market growth.

Access Complete Report @ https://www.marketresearchfuture.com/reports/inguinal-hernia-market-4418

Segmentation
The global Inguinal Hernia Repair Market Size is segmented on the basis of type, diagnosis, treatment and hernia mesh devices.
On the basis of types, market is segmented into direct and indirect hernia.
On the basis of diagnosis, the market is segmented into physical examination and imaging test. Imaging tests is further segmented into abdominal ultrasound, CT scan and Magnetic Resonance Imaging (MRI).
On the basis of treatment, the market is segmented into open hernia repair, laparoscopy, and others.
On the basis of hernia mesh devices, the market is segmented into synthetic mesh, and biologic mesh.

Cardiac Valve Market Research Forecast, Regional, Trends and Analysis to 2023

Cardiac Valve Market Growth And Application By Types (Trans-Catheter Heart Valve, Tissue Heart Valve, And Mechanical Heart Valve, And Others), By Diseases (Aortic Valve Replacement, Heart Valve Disease, Mitral Valve Stenosis, And Others), By Treatment (Valve Replacement, Valve Repair, And Others), And By End Users (Cardiac Research Institute, Hospital & Clinics, And Others) – Europe, Middle East & Africa Forecast Till 2023

The increased prevalence of heart-related diseases is promoting the use of cardiac valves to treat the conditions. Reports that analyze the medical device industry has been presented by Market Research Future, which produces reports on industry verticals that evaluate the market development and opportunities. Cardiac Valve Market is expected to grow at a CAGR of 6.5% during the forecasted period.

The sedentary lifestyles that are prevalent in urban areas have led to the spike in cardiovascular diseases, which is in turn expected to motivate the cardiac valve market in the coming years. Moreover, increased elderly population base and consumption of unhealthy food items are expected to alter the development of the cardiac valve market in the forecast period.

Segmental Analysis

The analysis of the segments the cardiac valve market is segmented on the basis of types, diseases, treatment, region, and end-users. Based on the types, the cardiac valve market is segmented into tissue heart valve, trans-catheter heart valve, mechanical heart valve, and others. Based on the disease, the cardiac valve market is segmented into heart valve disease, aortic valve replacement, mitral valve stenosis, and others. The segmentation of the cardiac valve market on the basis of treatments comprises of valve repair, valve replacement, and others. The end-users based segmentation of the cardiac valve market consists of hospital & clinics, cardiac research institute, and others. On the basis of regions, the cardiac valve market is segmented into Africa, Europe, APAC, the Middle East, and the Americas.

Browse Complete Toc :https://www.marketresearchfuture.com/reports/emea-cardiac-valve-market-610

Detailed Regional Analysis

The regional appraisal of the cardiac valve market notes that the Americas region largely comprises of South America and North America out of which North America governs the market due to the incidence of a huge number of patients with cardiac diseases, growing geriatric population, and mounting healthcare spending. The European region is the next highest revenue-generating region in the cardiac valve market. The more developed nations in Western Europe such as France, Germany, and the UK are controlling the major market portion, whereas the East European nations are also increasing at a substantial rate. Furthermore, factors like the evolving healthcare infrastructure and growing healthcare expenditure will lift the market evolution in this region. In the Asia Pacific region, growing government backing for research & development in the healthcare area and a mounting number of cardiovascular diseases are driving the progress of the market in this region. The Middle East & African region is anticipated to show a minimum market share owing to reduced availability of medical facilities, and limited development in the healthcare domain.

Request For Free Sample Copy :
https://www.marketresearchfuture.com/sample_request/610

Competitive Analysis

The profitability in the market is enhanced significantly by the existence of strong strategies deployed by market players. The identification and use of apposite media channels are expected to transform the market development in the coming years. The market is ushering in a phase of development that is expected to be motivated by the positive factors in the market. The demographics present in the market present a favorable outlook in terms of product expansion and future growth potential. The strategies in the market are being aimed at improving the overall progress of the market, with the business models taking into account all contingencies that may arise in the coming years. The pull created by the businesses in the market by positioning marketing policies and events is additionally growing the development of the market. The improvement of production resources is likely to stimulate the market’s improvement in the forecast period.

The substantial players in the cardiac valve market are Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), Lepu Medical Technology Co., Ltd. (China), Jenavalve Technology, Inc. (Germany), LivaNova PLC (U.K.), Symetis SA (Switzerland), CryoLife, Inc. (U.S.), TTK HealthCare (India), Medtronic, Colibri Heart Valve, LLC (U.S.), and Braile Biomédica (Brazil) to name a few.

Tuesday, June 16, 2020

Gene Therapy Market Growth Covering Competitive Scenario & Market Dynamics throughout 2025

Market Analysis

The Gene Therapy Market Growth was valued USD 524 million in 2018 and is likely to grow at a 40.7% CAGR between 2019- 2025, reveals the new Market Research Future (MRFR) report. Gene therapy includes repairing, replacing, or repressing dysfunctional genes that cause disease with an aim to re-establish normal function. It is a promising treatment for specific genetic diseases like cystic fibrosis, muscular dystrophy, and some inherited disorders, viral infections, and cancer. Gene therapy is used for eliminating cancerous cells, preventing cardiovascular diseases, blocking neurological disorders, and eliminating infectious pathogens. There are two types of gene therapy-germ-line/reproductive gene therapy and somatic cell gene therapy.

Various factors are adding to the global gene therapy market share. These factors, as per the new MRFR report, include increasing funding for R&D for gene therapy, availability of reimbursements, and increasing incidence of cancer as well as other target diseases. Besides, rising investments by key players, robust product pipeline, and demand for innovative medication is also adding market growth.

On the contrary, high gene therapy costs may limit the global gene therapy market over the forecast period.

Browse Complete Toc : https://www.marketresearchfuture.com/reports/gene-therapy-market-8399

Scope of the Report

The report categorizes the gene therapy market based on end user, indication, product, regions, and key players. This therapy is a method that includes the delivery of the nucleic acid polymer as a drug into the patient’s cells to treat disease. Gene therapy helps to fix a genetic issue at its source.

Market Segmentation

The Market Research Future Report provides a detailed segmental analysis of the gene therapy market by end user, indication, & product.

Based on product, the gene therapy market has been segmented into imlygic, zynteglo, strimvelis, zolgensma, yescarta, luxturna, kymriah, and others.

Based on indication, the gene therapy market has been segmented into genetic diseases/disorders, oncology, and others. Of these, the oncology segment will dominate the market over the forecast period for robust pipeline for cancer gene therapy and increasing incidence of cancer.

Based on end user, the gene therapy market is segmented into specialty treatment centers, hospitals and clinics, and others. Of these, hospitals & clinics will spearhead the market over the forecast period for the rising number of hospitals and hospitals being the foremost choice for disease treatment.

Request For Free Sample Copy :

https://www.marketresearchfuture.com/sample_request/8399

Regional Analysis

Based on the region, the global gene therapy market report covers the recent trends and growth opportunities across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, North America will dominate the market over the forecast period. Factors propelling the global gene therapy market growth in the region include the presence of top market players in the region, availability of favorable reimbursements, presence of advanced & well-developed healthcare infrastructure, high & growing healthcare expenditure, and rising incidence of chronic diseases.

The global gene therapy market in Europe is predicted to have a healthy growth over the forecast period for various innovative product launches made by industry players.

The gene therapy market in the Asia Pacific region is predicted to grow at the fastest pace over the forecast period. Factors propelling the global gene therapy market growth in the region include the approval & launch of gene therapy products, an increasing number of people susceptible to different chronic diseases, and rising awareness about gene therapy.

The global gene therapy market meanwhile in the MEA is predicted to have the smallest share over the forecast period for limited healthcare infrastructure.

Key Players

Key players profiled in the gene therapy market report include Lonza (Switzerland), Thermo Fisher Scientific Inc. (US), CEVEC (Germany), Bristol-Myers Squibb Company (US), Orchard Therapeutics plc (UK),Celgene Corporation (US), uniQure N.V. (Netherlands), Spark Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), Novartis AG (Switzerland), and Amgen, Inc. (US).

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid-19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.

Contact Lenses Market Forecast 2025: Emerging Technologies, Competition & Strategies of Key Players, Regional Analysis

Contact Lenses Market: Information by Wear Type (Daily Disposable Lenses, Disposable Lenses, Frequent Replacement Lenses and Conventional Lenses), by Type (Corrective Lens, Therapeutic Lenses and Cosmetic and Lifestyle Oriented Lens), by Material (Silicone Hydrogel Soft Contact Lens, Methacrylate Hydrogel Soft Contact Lens, Gas-Permeable Contact Lens and others), by Design (Spherical Lens, Toric Lens, Multifocal Lens and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2025

The Global Contact Lenses Market Forecast is expected to register a CAGR of 5.70% to reach USD 12,330.46 Million by 2025.Contact lenses are a boon for many people, no matter they prefer to wear it while going out, during sports activities, or use them as an alternative to glasses. They have different purposes and are suitable for all groups. With time, contact lenses have become more progressed and improved, and such improvements have resulted in a wide variety of lenses that are defined by their uses, life span, and characteristics.

Different Purposes

Contact lenses have different uses- decorative, cosmetic, therapeutic, and optical. Optical lenses are those that are used to correct the vision, therapeutic lenses help in the work of medicines which are used for treating eye conditions, cosmetic lenses help to enhance or change the wearer’s natural eye color and alter the appearance of the eyes, and decorative lenses are colored contacts that are used for fun which comes in various patterns for producing various effects.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/6210

Contact Lenses Vs. Glasses

Contact lenses provide functional benefits over glasses, especially in areas such as work-in humid climate, sports, and occupations where glasses are not compatible and are inconvenient with the equipment utilized, especially headgears. Below are some benefits that contact lenses provide over glasses.

Comfortable- First and foremost, contact lenses are more comfortable to wear as these, unlike glasses, do not press or rub against the temple and ears, or pinch the nose. Glasses, on the other hand, slide down the nose during perspiration
Unaffected by Weather- The best part about using contact lenses is that these will not fog up during the cold or get splattered during rain. Besides, these will not steam up from perspiration or body heat
Peripheral Vision- Contact lenses offer a better and wider peripheral vision compared to glasses. It moves along with the eyes, and the wearer looks through the lens’s clearest part- the optic zone. The frames on the glass, on the contrary, block the wearer’s peripheral vision, and when they move their eyes towards the side, they do not view through the optical center, thereby causing distorted and blurred vision
Do not Break Easily- The frames of the glasses are likely to crack or break on a number of occasions. The wearer may fall off their bike, may accidentally slip, or drop it on the ground. During such situations, there is no scope for contact lenses to break. As long as the wearer wears the lenses properly and cares for the same, they will not experience such damage. Though there is a possibility for lenses to tear or break, it is harder to destroy them in comparison to glasses
Ideal for Sports and Exercise- No matter the type, exercise, and sports include enough movements. These movements may lead to real slipping annoyance, especially when one wears glasses. Often, these fog up immensely with a minimal amount of sweating. Contact lenses, unlike glasses, move with the wearer perfectly. This way, they can easily focus on completely enjoying their activity or sport. Moreover, they do not fog up or mist while playing games or during a workout
Feel More Confident- Often, there are several negative stereotypes about those who wear glasses. Often, they may feel self-conscious or unattractive. Contact lenses are not noticeable; thus, the uneasiness about the need for vision correction disappears. Again, glasses may clash with the wearer’s overall look or outfit. But contact lenses will never detract the wearer from their look or outfit. They will offer style support and vision correction simultaneously
Aesthetic Benefits- The good news is, with contact lenses, the wearer can emphasize their natural beauty. Today lenses are available in multiple colors, thus letting the wearer experiment with various eye colors. Moreover, they can also pick transparent lenses for highlighting their natural eye color

Healthcare BPO Market Trends, Overview, Dynamics, Growth Factors for Business Expansion, Key Companies, Trends and Forecast 2024

Healthcare BPO Market Share, Growth And Industry Trends By Services (Pharmaceutical Service, Payer Services And Provider Services) And Region (Americas, Europe, Asia-Pacific And The Middle East & Africa) – Forecast Till 2023

Scope of the ReportHealthcare business process outsourcing (BPO) companies are involved in handling the non-core or supportive work of healthcare companies. These include pharmaceutical and biopharmaceutical companies. Medical coding and billing, claims processing, and data entry services are 3 major services conducted by healthcare BPO firms. The global healthcare BPO market looks at the factors and challenges of major healthcare organizations and its prospects for the period of 2019 to 2024 (forecast period).

Market OutlookThe global Healthcare BPO Market Trends is bound to touch USD 449,623.8 million by 2024. It is expected to display 12.3% CAGR over the forecast period. It is driven by the emphasis placed on patient care and need to curb healthcare expenses. For instance, the healthcare expenditure in the U.S. had reached USD 3.6 trillion in 2018. The need to lower spending and curtail expenses of surgeries as well as lower operating expenses can bode well for the market.

Rising patient inflow, increasing recovery audits, and need for minimizing critical mistakes are other factors which can induce the demand for healthcare BPOs. Emergence of various hospitals and their need to reduce reliance on government funds and improve their bottomline margins can drive the need for outsourcing services. Development of bots and virtual assistants to handle queries of patients can reduce the load of workers and assist them in focusing on pertinent tasks.

SegmentationBased on services, the global healthcare BPO market has been segmented into pharmaceutical service, payer services, and provider services. The pharmaceutical services need to scale its services by focusing on patient care and development of innovative technologies with the help of machine learning and artificial intelligence. The focus on research and development would require data analytics which can assist companies in making decisions pertaining to vaccines, drugs, and other potential launches.

Request For Free Sample Copy :

https://www.marketresearchfuture.com/sample_request/1335

Regional Analysis

The global healthcare BPO market, based on region, is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas are expected to lead the market owing to the need to curtail unnecessary overhead expenses in hospitals. Complex payor systems and long patient queues for processing of claims can drive the need for outsourcing services in the U.S. The need to provide high-volume services and requirement of capital for upgradation of hospital infrastructure can bode well for the global market in the coming years.

North America will generate the maximum revenue for the Americas healthcare BPO market.Europe accounted for 21.1% share of the global market. The well-developed healthcare infrastructure, disposable income levels of patients, and digital disruption are major factors bolstering market demand. Minimizing critical mistakes is a pivotal factor of the market with companies adhering to latest regulations set by medical boards such as HIPAA.

Poor processing of bills has led to losses which have culminated in shutdown of hospitals. Furthermore, training services provided to employees with regards to updates of latest technologies can augur favorably for the market.

APAC seems to be lucrative for the global healthcare BPO market owing to heavy investments from healthcare firms. Cost-efficiency measures undertaken by these firms for lowering the percentage of mistakes and reducing overhead expenses can lead to massive setups by parent healthcare organizations. India seems to contribute the maximum to the industry owing to their efficient training programs and skilled workforce. Adoption of medical transcription services and development of software applications which are compliant with regulations of international hospitals can augur favorably for the market.

Browse Complete Toc :

https://www.marketresearchfuture.com/reports/healthcare-bpo-market-1335

Competition OutlookHealthcare BPO companies currently operational include Sykes, HCL, Cognizant, ACCENTURE, IBM, QUINTILES, and INFOSYS.

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid-19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.

Insulin Pumps Market Analysis: Growth Factors Details for Business Development, Key Companies, Current Challenges and Forecast By 2023

Insulin Pumpss Market Share, Trends and Growth Analysis By Type (Traditional Insulin Pumpss, Smart Insulin Pumpss and Disposable Insulin Pumpss), Accessories (Insulin Reservoirs, Infusion Sets and Infusion Set Insertion Devices), Application (Type I Diabetes and Type II Diabetes), End User (Hospitals and Clinics, Home Care, Laboratories) and Region (North America, Europe, Asia-Pacific and Middle East & Africa) – Global Forecast till 2023

Market Analysis

The Insulin Pumps Market Analysis is likely to touch USD 8,520.9 million at an 8.4% CAGR between 2016- 2023, reveals the new Market Research Future (MRFR) report. An insulin pump, simply put, is a medical device that is used to administer insulin to treat diabetes mellitus. Disposable insulin pump and traditional insulin pump are the two types of insulin pumps available.

Numerous factors are adding to the insulin pump market growth. Such factors, as revealed by the latest MRFR report, include home infusion therapy, creation of artificial pancreas, increasing awareness about insulin delivering devices and diabetes, development of different types of insulin, and increasing incidence of diabetes. Besides, consumer information and professional programs offered by manufacturers are also encouraging the adoption of such pumps which is also adding to the insulin pump market share.

On the contrary, the dearth of skilled professionals for proper insulin pump handling, the high price of insulin pumps and analogs, and skin infections are factors that may limit the insulin pump sales.

Scope of the Report

The report categorizes the insulin pump market based on type, accessories, application, end user, regions, and key players. An insulin pump is a good substitute for multiple daily insulin injections. It provides flexible insulin therapy, especially when used together with carbohydrate counting and blood glucose monitoring.

Market Segmentation

The Market Research Future Report provides an inclusive segmental analysis of the insulin pump market based on type, accessories, application, and end user.

By type, the insulin pump market is segmented into the disposable insulin pump and the traditional insulin pump. Of these, the traditional insulin pump segment will lead the market over the forecast period.

By accessories, the insulin pump market is segmented into infusion set insertion devices, infusion sets, and insulin reservoirs. Infusion sets are again segmented into plastic cannula and steel cannula. Of these, insertion devices will dominate the market over the forecast period.

By type, the insulin pump market is segmented into Type I and Type II diabetes.

By end user, the insulin pump market is segmented into laboratories, home care, and hospitals & clinics. Of these, hospitals & clinics will have a major share in the market during the forecast period. It is predicted to touch USD 3,908.8 million by 2023.

Request For Free Sample Copy :

https://www.marketresearchfuture.com/sample_request/1637

Regional Analysis

By region, the global insulin pump market covers the growth opportunities and recent trends across Europe, North America, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, North America will lead the market over the forecast period for the rising incidence of diabetes. Besides, the presence of top industry players in the region, rising prevalence of obesity, availability of innovative medical facilities, high junk food consumption, technological advances, and consumers sedentary lifestyle are also adding market growth. The USA & Canada are the key contributors in the region.

The global insulin pump market in Europe is predicted to hold the second-largest share over the forecast period for the presence of several significant market players in the region, availability of advanced medical facilities, and technological advancements. The UK, Spain, Italy, Germany, and France are the country-specific markets in the region.

The global insulin pump market in the APAC region is predicted to grow at a fast pace over the forecast period. Factors propelling the global insulin pump market growth in the region include the growing health awareness, availability of advanced medical facilities, increase in disposable income, improving medical facilities in South Korea, Japan, Australia, India, & China, and increasing incidence of diabetes in Taiwan, Malaysia, Indonesia, India, and China.

The global insulin pump market in the MEA will have a small share during the forecast period for poor economies, strict government policies, lack of awareness, limited availability of technology, and less focus to improve healthcare.

Browse Complete Toc :https://www.marketresearchfuture.com/reports/insulin-pump-market-1637

Key Players

Leading players profiled in the global insulin pump market report include Sanofi (France), Medtronics (Ireland), Insulet Corporation (USA), F. Hoffmann-La Roche AG (Switzerland), Braun Melsungen AG (Germany), Becton Dickinson (USA), and Abbott Laboratories (USA).

Industry News

December 2019: Tandem’s insulin pump software gets US FDA approval.

Capsule Endoscopy System Market Share, Analysis, Growth Factors, Development Trends and Forecast to 2023

Capsule Endoscopy Market: Information by Component (Capsule Endoscopy, Capsule Endoscopy Data Recorder and Capsule Endoscopy Workstations), Endoscope Type (Capsule Cystoscopies and Capsule Neuro-Endoscopes), Product (Small Bowel Capsule, Esophageal Capsule and Colon Capsule), Application (Obscure Gastrointestinal Bleeding (OGIB), Crohn’s Disease and Small Intestine Tumor), End User (Hospitals, Clinics and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023

The Capsule Endoscopy System Market Share is growing pervasively due to the rising adoption of endoscopy procedures. Capsule endoscopy is used for the detection of polyps, inflammatory bowel disease, ulcers, and tumors of the small intestine. The growing prevalence of small intestinal disorders and the increasing geriatric population are the major growth drivers of the market. Moreover, factors such as increasing funding & reimbursement for screening & treatment using endoscopic techniques push market growth.

According to Market Research Future (MRFR), the global capsule endoscopy market is poised to reach USD 967.4MN by the end of 2023, registering 8.82% CAGR during the review period (2018 – 2023). Additionally, spreading awareness about the availability & benefits of capsule endoscopy procedures is substantiating the market growth. Also, the rising demand for effective diagnostic & therapeutic options impacts the growth of the capsule endoscopy system market positively.

On the other hand, the risks & complications associated with the capsule endoscopy are anticipated to hamper the market growth. Also, the lack of skilled physicians might constrain the growth of the capsule endoscopy market share. Nevertheless, augmenting demand & preference for less invasive treatment methods would support the increase of the capsule endoscopy market size during the forecast period.

Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/1359

Global Capsule Endoscopy Market – Segments

The report segmented into six market dynamics;

By Component : Capsule endoscopy, Capsule Endoscopy Data Recorder, Capsule Endoscopy Workstations, and others.

By Endoscope Type : Capsule Cystoscopies, Capsule Neuro-Endoscopes, and others.

By Product : Small Bowel Capsule, Esophageal Capsule, Colon Capsule, and others.

By Application : Obscure Gastrointestinal Bleeding (OGIB), Crohn’s Disease, Small Intestine Tumor, and others.

By End User : Hospitals, Clinics, and others.

By Regions : Europe, Americas, Asia-Pacific, Middle East & Africa, and Rest-of-the-World.

Global Capsule Endoscopy Market – Geographical Analysis

North America possesses a significant share in the global capsule endoscopy market. The exponential growth attributes to the presence of a large number of major market players and patients suffering from intestinal diseases. Besides, the increasing emphasis on advanced diagnosis & treatment processes for cancer and gastrointestinal disorders is a key growth driver. Also, factors such as the availability of advanced technologies, high healthcare expenditure, and government support for research & development increase the region’s capsule endoscopy market size.

Moreover, rapid developments of novel biosimilars and drugs for the treatment of myriads of diseases act as a major tailwind behind the regional market growth. Besides, rising government support for R&D activities and growing focus on the development of new capsule endoscopy procedures contribute to the regional market growth. The North American capsule endoscopy market is estimated to retain its dominance over the global market throughout the forecast period.

Europe stands second in the global capsule endoscopy market, driven by the rising prevalence of Crohn’s disease and ulcerative colitis in the region. Also, factors such as improving economic conditions and massive development in the healthcare domain impact the regional market growth positively. Research institutions emphasis on updating technologies used or new & advanced diagnosis & treatment methods, which, in turn, drives the regional market growth.

Moreover, the presence of advanced hospital infrastructures and skilled healthcare professionals is increasing the capsule endoscopy system market in the region. Additionally, various strategic initiatives undertaken by the companies operating in the regional market are expected to boost Europe’s capsule endoscopy market share globally. The European capsule endoscopy market is likely to grow at a significant CAGR during the review period.

The capsule endoscopy market in the Asia Pacific region is growing rapidly. Factors such as the vast population base and the presence of rapidly developing countries like India and China in the region offer tremendous growth opportunities. Furthermore, the increasing numbers of patients who are suffering from cancer & gastrointestinal diseases create a vast market demand for various diagnosis & treatment methods.

Moreover, the augmenting demand for quality treatment & diagnostic process, proliferating healthcare technology, and increasing uptake of endoscopy procedures in the region provide impetus to market growth. The APAC capsule endoscopy market is estimated to register a phenomenal CAGR throughout the analysis period.

Browse Complete Report: https://www.marketresearchfuture.com/reports/capsule-endoscopy-market-1359

Global Capsule Endoscopy Market - Competitive Analysis

Highly competitive, the Capsule Endoscopy market appears diversified due to the presence of several major players. To gain a larger competitive share, players adopt strategic initiatives such as mergers & acquisitions, expansion, collaboration, and product launch. They make huge investments to drive R&D activities and expansion plans. Further, market players work with physicians, nurses, and technicians around the world to identify unaddressed needs.

Major Players:

Players leading the capsule endoscopy market include Olympus Corporation, Medtronic PLC, IntroMedic, CapsoVision Inc., Chongqing Jinshan Science & Technology, Fujifilm Holding Corporation, AccuRead Endoscopy Inc., and RF Co.Ltd, among others.

Industry/Innovation/Related News:

May 07, 2020 --- A team of researchers set out to assess the role of small-bowel capsule endoscopy (SBCE) in patients and to determine SBCE findings at diagnosis can predict disease outcome. The researchers are variously affiliated with the Royal Hallamshire Hospital, Academic Unit of Gastroenterology, Sheffield, UK, the Academic Unit of Gastroenterology, and others, assessed 177 patients with SNVA, IELs +/-crypt hyperplasia on duodenal histology. The research findings indicate that all these patients had an equivocal diagnosis of celiac disease, and about one in three patients had a positive SBCE.

CBD Oil Market Analysis: Historical, Current and Projected Market Size, Competitive landscape & Forecast 2024

According to Market Research Future CBD Oil (Cannabidiol Oil) Market: Information by Type (Hemp-Derived & Marijuana-Derived), Application (Cosmetics Industry, Food Industry, Pharmaceuticals Industry & Others) and Region (Americas, Europe, Asia-Pacific and Middle East &Africa) – Global Forecast till 2024

Cannabidiol (CBD) oil is a product derived from cannabis, a chemical found naturally in marijuana plants. Health benefits of CBD oil have found many takers in light of the recent legalization of marijuana in certain nations. The global CBD Oil Market Analysis report by Market Research Future (MRFR) provides analysis on favorable regulations, production techniques, and future trends for the period of 2019 to 2024 (forecast period).

Market Scope

The global CBD oil market is projected to exhibit a CAGR of 38.45% over the forecast period. It can touch a value of USD 3,782.32 million by 2024. CBD oil is been used in treatment of various conditions such as anxiety, depression, pain alleviation, acne reduction, and palliative care. The large potential for CBD oil due to the legalization of marijuana is bound to be lucrative for the market. According to a survey by National Center for Biotechnology Information (NCBI) between 2017 and 2018, nearly 62% of the population used CBD-based products for treating medical conditions.

Rise in research funding due to its health benefits by private research institutes and government organizations can bode well for the market. According to the National Institute of Drug Abuse, close to 140 million was expended on research of cannabis. Lax of policies with regards to marijuana is likely to favor the market in the coming years. Advocation of CBD by social media influencers, marketing campaigns by industry participants, and government acceptance can drive up the sales of CBD oil.

However adverse effects of cannabis can threaten the growth of the global CBD oil market.

Request For Free Sample Copy :
https://www.marketresearchfuture.com/sample_request/7355

Segmentation

By type, the global CBD oil market has been segmented into hemp-derived and marijuana-derived types. Hemp-derived CBD oil will lead in the market at a stellar CAGR to reach USD 2,092.97 million valuation by the end of 2024. The large market share can be credited to the varying concentration of tetrahydrocannabinol (THC) levels in hemp and marijuana. Hemp contains a very low concentration of THC, i.e., 0.3% or less.

Major market applications include cosmetics, pharmaceuticals, food, and others. The cosmetic industry accounted for a major market share and touted to exhibit 38.80% CAGR during the forecast period. Applications of CBD oil in unclogging pores, skin moisturization, and anti-inflammation solutions can fuel the segment growth.

Regional Analysis

The Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA) are regions acting as the epicenter for the expansion of the global CBD oil market.

The Americas is bound to dominate the global market owing to the high consumption of cannabis-based products. According to the WHO, marijuana is being consumed by nearly 147 million individuals. Moreover, 22.2 million Americans in the age group of 12 and above has been consuming CBD for other reasons creating opportunities for the market. New product launches is evidence of the upward growth trajectory of the market. For instance, Isodiol International launched wellness products for pets.

Europe held the second largest share owing to large awareness levels of the clinical applications of cannabis. Meanwhile, APAC accounted for the third position in the global CBD oil market and can exhibit a robust CAGR during the forecast period. Legalization of marijuana in Australia offers a large potential of growth to the market.

Browse Complete Toc :https://www.marketresearchfuture.com/reports/cbd-oil-market-7355

Competition Outlook

Absolute Terps, Emblem Cannabis, Aurora Cannabis, Medical Marijuana, Inc., ENDOCA, Kazmira LLC, Curaleaf Holdings, Inc., HempLife Today, Freedom Leaf, Inc., Green Roads of Florida, LLC, MedMen Enterprises Inc., CBD American Shaman, Aphria Inc., Canopy Growth Corporation, Pharmahemp, Folium Biosciences, CV Sciences, Inc., Charlotte’s Web Holdings, Inc., NuLeaf Naturals, and Whistler Medical Marijuana Corporation are notable players of the global CBD oil market. Launch of new lineups seems to be the primary strategy of these players. Recently, Medical Marijuana Inc. has expanded its line of CBD oil products with new flavors of tangerine and strawberry.

Cancer Biomarkers Market Forecast 2023: Overview, Dynamics, Supply & Demand, Analysis

Cancer Biomarker Market Research Report: By Types (Protein Biomarker, Genetic Biomarker), By Applications (Diagnostic, Prognostic, Therapeutic), By End Users (Pharmaceutical and Biotechnology Companies, Diagnostic Companies) – Forecast till 2023

Market Analysis

The Cancer Biomarkers Market Forecast is projected to grow at a healthy CAGR between 2017-2023, reveals the new Market Research Future (MRFR) report. Cancer biomarkers, simply put, are processes or substances that are indicative of the prevalence of cancer in the human body. Imaging, glycomic, proteomic, epigenetic, and genetic biomarkers can be utilized for the diagnosis, prognosis, as well as epidemiology of cancer.

Numerous factors are adding to theglobal cancer biomarkers market growth. Such factors, according to the recent MRFR report, include the development of specific drugs, investments through private and government funds in research that is cancer-related, improved precision as well as speed of diagnosis, encouragement by the FDA for biomarker development, extensive research and development of cancer biomarkers, and adoption of western lifestyles especially in developing regions. The increasing usage of biomarkers in tumor profiling and the rising prevalence of cancer is also adding to the cancer tumor profiling market growth.

On the contrary, favourable reimbursement and regulatory scenario are factors that may limit the global cancer biomarkers market growth over the forecast period.

Market Segmentation

The scope of the report includes an inclusive segmental analysis of the global cancer biomarkers market based on end users, applications, and types.

By type, the cancer biomarkers market is segmented into genetic biomarkers, protein biomarkers, and others. Of these, protein biomarkers will lead the market over the forecast period.

By application, the cancer biomarkers market has been segmented into therapeutic, prognostic, and diagnostic. Diagnostic is again segmented into non-imaging and imaging. Of these, diagnostic will dominate the market over the forecast period.

By end users, the cancer biomarkers market is segmented into clinical laboratories, healthcare IT/big data companies, diagnostic tool companies, and pharmaceutical & biotechnology companies.

Request For Free Sample Copy :

https://www.marketresearchfuture.com/sample_request/5378

Regional Analysis

By region, the global cancer biomarkers market covers the growth opportunities and recent trends across Europe, the Americas, the Middle East & Africa (MEA), and the Asia Pacific (APAC). Of these, North America will dominate the market over the forecast period for the huge investments made on cancer detection and diagnosis and rising prevalence of cancer. The US is the key contributor in the region for growing medical tourism, growing cases of cancer, and increasing demand for investment in R&D. Besides, increasing use of biomarkers both in drug discovery as well as development by the region’s leading pharmaceutical companies, the use of omics technology for biomarker discovery, demand for personalized medicine, and increasing support from the government for the discovery as well as the development of biomarkers are also adding market growth.

The cancer biomarker market in Europe is predicted to hold the second-largest share over the forecast period for the sufficient accessibility of funds for research and the rising number of clinical trials. The UK, France, and Germany are the key contributors in this region for the growing demand for advanced diagnostic devices and tools in these countries.

The cancer biomarker market in the APAC region is predicted to grow at a quick pace over the forecast period for the accessibility of skilled experts such as diagnostic specialists and technicians. The increasing population in India, as well as China, increase in medical tourism, taking into consideration the diagnosis and treatment of cancer, rising prevalence of cancer, and increasing investments by private and public sectors in diagnosis & treatment of cancer are also adding market growth.

The cancer biomarker market in the MEA will have a small share during the forecast period for limited accessibility of medical facilities and funds and a low incidence of cancer. The market in the Middle East has a big share for the presence of developed countries in the region, such as Saudi Arabia, Oman, Qatar, and Kuwait. Meanwhile, owing to huge opportunities for market development, the market in Africa is predicted to have healthy growth.

Browse Complete Toc :
https://www.marketresearchfuture.com/reports/cancer-biomarker-market-5378

Key Players

Eminent players profiled in the cancer biomarker market report include Illumina Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Novartis AG (Switzerland), QIAGEN N.V (U.S.), GlaxoSmithKline plc. (U.S.), Pfizer Inc. (U.S.), Merck & Co., Inc. (U.S.), Eli Lilly and Company (U.S.), Bio-Rad Laboratories (U.S.), Bristol-Myers Squibb (U.S.), PerkinElmer, Inc. (U.S.), Abbott Laboratories (U.S.), Becton Dickinson (U.S.), and F. Hoffmann-La Roche AG (Switzerland).

Industry News

February 2020: Researchers at Wageningen University and the University of Twente have created a nanosensor that can detect biomarkers for cancer accurately in a wide range of concentrations ranging from 10 particles/microliter up to 1 million/microliter.

Contract Research Organization (CRO) Market Share: Growth Factors, Market Drivers, Segmentations, Key Players, Analysis & Forecast by 2023

Contract research organizations (CROs) are firms which provide clinical and other services to large pharmaceutical and biopharmaceutical companies at economical prices. Their main focus is to bring down prices of blockbuster drugs and manufacture it on a large scale while making it feasible for the original manufacturers. The global Contract Research Organization (CRO) Market Share report by Market Research Future (MRFR) has been compiled with respect to the changing economy and prevalence of various diseases. It contains insights, drivers, and roadblocks for end-users for the period of 2018 to 2023 (forecast period).

Market Scope

The global contract research organization (CRO) market is predicted to expand at 11.48% CAGR during the forecast period. Research and manufacture of medical devices and therapeutic drugs are prime drivers of the market. Increasing investments in research and development, emergence of pharmaceutical and biopharmaceutical companies, and patent expiration of drugs will bolster the market growth.

The high need to lower costs across all phases of clinical research will play a major role in the market in the coming years. This trend can be credited to the requirement for effective treatment of Alzheimer’s, cancer, and others. The privatization of clinical trials in the healthcare industry can further push this trend. Stringent regulations on drugs and continuous monitoring to reduce the number of adverse effects will bode well for the market. Collaborations and partnerships will positively impact the market. CROs can reduce the time to bring a product to market, improve quality, and show efficiency in its production.

However, high labor costs, volatile prices of exchange rates, and structural changes in employment are restraining factors of the market.

Segmentation

The global contract research organization market is segmented on the basis of segment, clinical trial phase, and end users.

Segments in the market are clinical development, drug discovery, post marketing services, and others.

On the basis of clinical trial, the market is segmented into preclinical trials, phase I, phase II, phase III, phase IV, and others.

On the basis of end users, the contract research organization market is segmented into academic institutes, pharmaceutical/ biotechnology companies, medical devices companies, and others.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/3322

Regional Analysis

The Americas, Asia Pacific (APAC), Middle East & Africa (MEA), and Europe are major regions of the global contract research organization (CRO) market.

The Americas is projected to dominate the global CRO market owing to the large patient pool, prevalence of chronic diseases, and a well-developed healthcare sector. The change in lifestyle and large allocation of healthcare expenditure for the public can bolster the regional market growth. Developed economies such as the U.S. and Canada and the outsourcing of drug development to developing economies for saving manufacturing costs and time will augur favorably for the market.

Europe is the second-largest region in the market owing to government support for research and development, abundance of funds for research, and a large patient pool. France, Germany, and the U.K. are countries which can contribute to the region.

APAC will be highly lucrative for the global contract research organization (CRO) market due to the large manufacturing bases in China and India and lax regulations. According to the Indian Brand Equity Foundation (IBEF), the India healthcare market value can skyrocket to USD 280 billion by 2020 by showcasing a CAGR of 22.87% over the assessment period.

Browse Complete Toc :

https://www.marketresearchfuture.com/reports/contract-research-organization-market-3322

Competition Outlook

Laboratory Corporation of America Holdings, INC Research LLC, ICON plc., PAREXEL International Corporation, PRA Health Sciences, Inc., Pharmaceutical Product Development, LLC., QuintilesIMS, and others are key players of the contract research organization market.

Endoscopy Device Market Growth Insights: Growth Factors, Market Drivers, Segmentations, Key Players, Analysis & Forecast by 2023

Endoscopy Device Market Growth And Trends Analysis By Type, (Flexible Endoscopes), Therapy (Gastroscopy), Treatment & Procedure (Abdominal, Gynecologic And Pelvic Organ Conditions), Application, (Gastrointestinal Endoscopy), Accessory & Processor, Technology, And End User – Global Forecast Till 2023

The Endoscopy Device Market Growth is growing pervasively, mainly due to the technological advances that have improved the performances of these devices. Besides, factors such as increasing funding & reimbursement for screening & treatment with endoscopic techniques are promoting the endoscopy device market growth. Moreover, the growing prevalence of chronic diseases such as cancer, gastrointestinal disorders, and obstetrics/gynecology diseases escalates market growth to furthered height.

According to Market Research Future (MRFR), the global endoscopy device market is poised to reach USD 42,342.4 MN by the end of 2023. In its recent endoscopy device market forecast, MRFR also asserts that the market would register a 6.3% CAGR throughout the review period (2017 – 2023). Additionally, well-spread awareness towards the availability and benefits of endoscopy devices are substantiating the market growth.

Market Drivers and Restraints:

Drivers:

Rising demand for effective diagnostic & therapeutic options.
Shift towards less invasive treatment methods.
Increasing geriatric population.

Restraints:

Infections and complications caused by endoscopy devices.
High cost of endoscopy devices.
Lack of knowledge about the availability & benefits of endoscopy devices.

Request For Free Sample Copy :

https://www.marketresearchfuture.com/sample_request/1967

Global Endoscopy Device Market – Segments

The analysis has been segmented into six main dynamics to widen the scope of understanding,

By Type : Rigid Endoscopes, Flexible Endoscopes, Capsule Endoscopes, Robot-Assisted Endoscopes, Surgical Endoscopes, and other Endoscopes.

By Therapy: Colonoscopy, Arthroscopy, Gastroscopy, Laparoscopy, Endoscopic Retrograde Cholangiopancreotography, Sigmoidoscopy, Cholangiopan Creotography, Ureteroscopy, Cystoscopy, and others.

By Treatment & Procedure: Abdominal, Gynecologic & Pelvic Organ Conditions, Joint & Orthopedic Conditions, Lung & Airway Conditions, Lower Gastrointestinal Conditions, Upper Gastrointestinal Conditions, Urinary System Conditions, and others.

By Application : Gastrointestinal Endoscopy, Arthroscopy, Obstetrics/Gynecology Endoscopy, Urology Endoscopy, Bronchoscopy, Mediastinoscopy, Otoscopy, and others.

By End-User : Critical Care, Gastroenterologists, General & Pediatric Surgeons, Obstetricians-Gynecologists (ob/gyns), Orthopedic Surgeons, and others.

By Regions : Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-World.

Browse Complete Toc :

https://www.marketresearchfuture.com/reports/endoscopy-devices-market-1967

Global Endoscopy Device Market – Regional Analysis

North America dominates the global endoscopy device market. The largest share of the market attributes to the strong economic conditions, massive development in the healthcare domain, and the focus of research institutions on updating technology for new & advanced diagnosis & treatment methods. Moreover, factors such as the presence of advanced hospital infrastructures and skilled healthcare professionals are increasing the region’s endoscopy device market share in the global market. The North American endoscopy device market is estimated to retain its leading position throughout the assessment period.

Europe stands second in the global endoscopy device market, heading with the increasing emphasis on rapid diagnosis & treatment of cancer and gastrointestinal diseases. Besides, factors such as the rising government support for R&D activities and growing focus on the development of new devices in the region are contributing to endoscopy device market growth. Driven by the growing numbers of specialty services offered by various healthcare providers, the European endoscopy device market is likely to grow at a significant CAGR during the review period.

The Asia Pacific endoscopy device market is rapidly emerging as a promising market globally. Rapidly developing countries like India and China are encouraging the growth of the regional market. Furthermore, the increasing patient population of cancer and gastrointestinal diseases is creating a vast market demand for various diagnosis & treatment methods. Moreover, the augmenting demand for quality devices, proliferating healthcare technology, and increasing uptake of endoscopy devices in the region are providing impetus to market growth. The APAC endoscopy device market is estimated to register a phenomenal CAGR throughout the analysis period.

Global Endoscopy Device Market – Competitive Analysis

Highly competitive, the endoscopy device market appears to be diversified with the presence of a large number of players. These players make substantial investments in R&D to drive innovations and strategic initiatives. To gain a larger competitive advantage in the market, players adopt strategies such as mergers & acquisitions, expansion, collaboration, and product launch. To increase their global footprints, players acquire small yet promising companies from the emerging markets.

They compete against each other based on the quality, reliability, and cost of the devices. Looking at the huge demand for innovative technologies that can help clinicians to provide the best possible treatments to the patients in need, manufacturers create unique solutions that can meet the challenging needs of consumers. They work with physicians, nurses, and technicians around the world, which further helps them to identify unaddressed needs.

Major Players:

Players leading the endoscopy device market include Integrate Endoscopy, Cogentix Medical, J&J services Inc, Interscope Inc., Shaili Endoscopy, Cantel Medical, Cognetix, Micro-Tech Endoscopy, Stryker, Karl Storz Gmbh & Co. KG, Olympus, Fujifilm, Richard Wolf, and Pentax Medical, among others.

Industry/Innovation/Related News:

January 16, 2020 — Hoya Corp. (the US), a subsidiary Pentax Medical, announced the FDA 510(k) clearance for its Imagina endoscopy system, launching the device in the U.S. The Imagina system is designed to perform gastrointestinal procedures at ambulatory surgery centers (ASCs). The Imagina i10c series is the only endoscope platform with a real-time, digital image enhancement system that offers an enhanced view of the texture of the mucosal surface and blood vessels.